Home › Bids
› Maryland › Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists ve
Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV
This bid is closed — responses were due July 30, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This bid solicits proposals for research comparing GLP-1 receptor agonists and DPP-4 inhibitors for treating alcohol and substance use disorders in people living with HIV, with a focus on improving HIV-related outcomes and overall health benefits.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Research Services: Role of GLP-1 receptor agonists vs. DPP-4 inhibitors for alcohol and substance use disorders in people living with HIV
1
project
$1,500,000.00
$1,500,000.00
Professional Services
Estimated Bid Value
$1,500,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds the 3 documents, contracting-officer contacts and AI response outlines.